News & information from UB, New York's flagship university
For help reaching an expert on deadline, please contact UB's media relations team at 716-645-6969 or ub-news@buffalo.edu.
Note to members of the news media:
The correct name of the university is “University at Buffalo,” not “University of Buffalo.”
Lucy Mastrandrea
Professor of Pediatrics and Chief, Division of Endocrinology/Diabetes
Jacobs School of Medicine and Biomedical Sciences at University at Buffalo
AREAS OF EXPERTISE:
Type 1 and 2 diabetes in children and adolescents, obesity in children and adolescents, GLP-1 medications for weight management, endocrine disorders
Lucy Mastrandrea can talk to the media about children and adolescents with obesity, Type 1 and Type 2 diabetes, growth hormone deficiency, late endocrine effects of childhood cancer and congenital adrenal hyperplasia. She has studied novel therapies that might protect pancreatic beta cells from auto-immune destruction in adults and children newly diagnosed with Type 1 diabetes.
Mastrandrea can also discuss both behavioral and pharmaceutical strategies to improve success with weight control. She has led research showing that many of the weight loss drugs known as GLP-1 medications, which have been used in adults for years, are also safe and effective to use in children and adolescents with obesity.
A physician with UBMD Pediatrics, Mastrandrea is also chief of the Division of Endocrinology/Diabetes in Golisano Children’s Hospital of Buffalo.
CONTACT:
Lucy Mastrandrea, MD, PhD
Professor of Pediatrics and Chief, Division of Endocrinology/Diabetes
Jacobs School of Medicine and Biomedical Sciences at University at Buffalo
- ldm@buffalo.edu
- Lucy Mastrandrea's website
- Lucy Mastrandrea can be reached through Ellen Goldbaum in University Communications at 716-645-4605 or goldbaum@buffalo.edu, or Douglas Sitler in University Communications at 716-645-9069 or drsitler@buffalo.edu.